Intravesical idarubicin: A dose-finding study

Cancer Chemotherapy and Pharmacology

Volumn 38, Issue 1, 1996, Pages 102-105

  Boccardo, Francesco ^a   Cannata, Daniela ^a,c   Cussotto, Michele ^b   Schenone, Maurizio ^b   Curotto, Antonio ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

Author keywords

Chemoprophylaxis; Cumulative toxicity; Endovesical instillations; Idarubicin

Indexed keywords

ANTHRACYCLINE DERIVATIVE; IDARUBICIN;

AGED; ARTICLE; BLADDER TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTITIS; DRUG WITHDRAWAL; FEMALE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL;

EID: 0029918028     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050454     Document Type: Article

References (12)

1. Boccardo F, Cannata D, Rubagotti A, Guarneri D, Decensi A, Canobbio L, Curotto A, Martorana G, Pegoraro C, Selvaggi F, Salvia G, Comeri G, Bono A, Borella T, Giuliani L (1994) Prophylaxis of superficial bladder cancer with mitomycin or interferon alpha-2b. Results of a multicentric Italian study. J Clin Oncol 12:7
2. Calais da Silva F (1989) The role of adriamycin and epirubicin in superficial bladder cancer and carcinoma in situ. In: Murphy GP, Khoury S (eds) Therapeutic progress in urological cancers. Alan R Liss, New York, p 401
3. Casazza AM (1978) Preclinical studies for the evaluation of new anthracycline analogs. Chemother Oncol 2:310
4. Heney NM, Ahmed S, Flanagan MJ (1983) Superficial bladder cancer: progression and recurrence. J Urol 130:1083
5. Jakse G, Hofstadter F, Marberger H (1984) Topical doxorubicin hydrachloride therapy for carcinoma in situ of the bladder: a follow-up. J Urol 131:41
6. Kurth KH, Vijgh WJF van der, Kate F ten, Bogdanowicz JF, Carpentier PJ, Reyswoud I von (1991) Phase I/II study of intravesical epirubicin in patients with carcinoma in situ of the bladder. J Urol 146:1508
7. Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA, Sullivan J, Sarosdy MF, Crissman JD, Coltman CA (1989) A randomized trial of intravesical doxorubicin and immunotheraphy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med 325:1205
8. Matsumara Y, Tsushima T, Ozaki Y, Yoshimoto J, Akagi T, Obama T, Nasu Y, Ohmori H (1986) Intravesical chemotherapy with 4′-epi-adriamycin in patients with superficial bladder tumors. Cancer Chemother Pharmacol 16: 176
9. Rawls WH, Lamm DL, Loe BA, Crawford ED, Sarosdy MF, Montie JE, Grossman HB, Scardino PT (1990) Fatal sepsis following intravesical bacillus Calmette-Guérin administration for bladder cancer. J Urol 144:1328
10. Schultze-Seeman W, Mross K, Burk K, Sommerkamp H (1994) Intravesical idarubicin - a phase-I study. Urol Res 22: 99
11. Serretta V, Piazza S, Messina G, Vaccarella V, Gange E, Piazza B (1995) L'idarubicina nella terapia endovescicale degli uroteliomi vescicali superficiali. Studio di fase I-II. Proceedings, 68th Congresso Nazionale della Società Italiana di Urologia, Roma, 2-5 luglio 1995, abstract book, p 163
12. Torti FM, Lum BL (1984) The biology and treatment of superficial bladder cancer. J Clin Oncol 2: 505